Literature DB >> 32319712

Acceptability and outcomes of multigene panel testing among young Black breast cancer survivors.

Claire C Conley1, Jennifer D Garcia1, Cristi Radford2,3, Richard R Reich1, Alvaro N Monteiro1, Tuya Pal3, Susan T Vadaparampil1.   

Abstract

Entities:  

Keywords:  breast cancer; genetic testing; survivorship; update testing

Mesh：

Year:  2020        PMID： 32319712      PMCID： PMC7578013          DOI： 10.1111/tbj.13848

Source DB:  PubMed          Journal:  Breast J        ISSN： 1075-122X            Impact factor:   2.431


× No keyword cloud information.
  6 in total

1.  A high frequency of BRCA mutations in young black women with breast cancer residing in Florida.

Authors:  Tuya Pal; Devon Bonner; Deborah Cragun; Alvaro N A Monteiro; Catherine Phelan; Lily Servais; Jongphil Kim; Steven A Narod; Mohammad R Akbari; Susan T Vadaparampil
Journal:  Cancer       Date:  2015-08-19       Impact factor: 6.860

2.  Breast cancer in the personal genomics era.

Authors:  Rachel E Ellsworth; David J Decewicz; Craig D Shriver; Darrell L Ellsworth
Journal:  Curr Genomics       Date:  2010-05       Impact factor: 2.236

3.  Patient satisfaction with cancer genetic counseling: a psychometric analysis of the Genetic Counseling Satisfaction Scale.

Authors:  Tiffani A DeMarco; Beth N Peshkin; Bryn D Mars; Kenneth P Tercyak
Journal:  J Genet Couns       Date:  2004-08       Impact factor: 2.537

4.  Preferences for multigene panel testing for hereditary breast cancer risk among ethnically diverse BRCA-uninformative families.

Authors:  Belinda Vicuña; Harold D Delaney; Kristina G Flores; Lori Ballinger; Melanie Royce; Zoneddy Dayao; Tuya Pal; Anita Y Kinney
Journal:  J Community Genet       Date:  2017-10-02

5.  Meta-analysis of BRCA1 and BRCA2 penetrance.

Authors:  Sining Chen; Giovanni Parmigiani
Journal:  J Clin Oncol       Date:  2007-04-10       Impact factor: 44.544

6.  Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.

Authors:  Thomas Paul Slavin; Mariana Niell-Swiller; Ilana Solomon; Bita Nehoray; Christina Rybak; Kathleen R Blazer; Jeffrey N Weitzel
Journal:  Front Oncol       Date:  2015-09-29       Impact factor: 6.244
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.